Log In
Print
BCIQ
Print
Print this Print this
 

ImmuFact IMP321

  Manage Alerts
Collapse Summary General Information
Company Prima BioMed Ltd.
DescriptionNatural human T cell immunostimulatory factor derived from soluble lymphocyte activation gene 3 (LAG3)
Molecular Target Major histocompatibility complex class II (MHCII) ; Lymphocyte-activation gene 3 (LAG3) (CD223)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today